Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Ipatasertib|DRUG: Capecitabine|DRUG: Eribulin|DRUG: Carboplatin|DRUG: Gemcitabine
Sponsor: MedSIR
Collaborators: Hoffmann-La Roche